
Mark Springel
Principal · Vida Ventures
PrincipalBoston, MA
Mark Springel, Ph.D., is a Principal at Vida Ventures focusing on private and public investments in oncology, immunology, neuroscience and rare disease. He serves on the board of Third Arc Bio and was previously a board observer for Capstan Therapeutics and Vigil Neuroscience. He completed his Ph.D. at Harvard Medical School.
Board seats
11 current
· PUBLIC SOURCES
Credited hits
2
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Mark Springel, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Capstan Therapeuticsacquired
Previously board observer; acquired by AbbVie, per Vida team page.
Source: vidaventures.com
- Vigil Neuroscienceacquired
Previously board observer; acquired by Sanofi, per Vida team page.
Source: vidaventures.com
Board seats
Current board seats · 1
- Third Arc BioSource: vidaventures.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- vidaventures.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Mark Springel. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Mark Springel.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Mark Springel — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
